A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias

American Journal of Clinical Pathology

Volumn 109, Issue 1, 1998, Pages 24-31

  Cox, M Christina ^a,c   Maffei, Laura ^a   Buffolino, Sonia ^b   Del Poeta, Giovanni ^a   Venditti, Adriano ^a   Cantonetti, Maria ^a   Aronica, Germano ^a   Aquilina, Piera ^a   Masi, Mario ^a   Amadori, Sergio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NONE   (Italy)

Author keywords

bcr abl gene translocation; Fluorescence in situ hybridization FISH ; Leukemia diagnosis; Ph positive leukemias

Indexed keywords

BCR ABL PROTEIN; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; LEUKEMIA; MAJOR CLINICAL STUDY; MYELOPROLIFERATIVE DISORDER; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031983562     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/109.1.24     Document Type: Article

References (46)

1. de Klein A, van Kessel AG, Grosveld G, et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature. 1982;300:765-767.
2. Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature. 1985;315:550-552.
3. Hagemeijer A. Chromosome abnormalities in CML. Baillieres Clin Hematol 1987;1:963-981.
4. Hermans A, Heisterkamp N, von Lindern D, et al. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell. 1987;70:1584-1591.
5. 1 chromosome in monozygotic twins. Arch Dis Child. 1977;52:72-80.
6. 1-positive chronic myelogenous leukemia. Ann Intern Med. 1975;83:820-823.
7. Price CM, Rassool F, Sivji MKK, et al. Rearrangement of the breakpoint cluster region and expression of P210 bcr-abl in a masked Philadelphia chromosome-positive acute myeloid leukemia. Blood. 1988;72:1829-1832.
8. Tachibana N, Raimondi SC, Lauer SJ, et al. Evidence for a multi-potential stem cell disease in some childhood Philadelphia chromosome-positive acute lymphoblastic leukemias. Blood. 1987;70:1458-1461.
9. Fialkow PJ, Jacobson RJ, Papayannopoulou T. Chronic myelogenous leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med. 1987;63:125-130.
10. Elephant AG, Cory S. bcr-abl-induced cell lines can switch from mast cell to erythroid or myeloid differentiation in vitro. Blood. 1992;79:1271-1281.
11. Selleri L, von Lindern M, Hermans A, et al. Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia type 7kb transcript. Blood. 1990;75:1146-1153.
12. Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood. 1996;88:2375-2384.
13. Shtivelman E, Lifshitz B, Gale RB, Roe BA, Canaani E. Alternative splicing of RNAs transcribed from the abl gene and from the bcr-abl fused gene. Cell. 1986;47:277-284.
14. Saglio G, Pane F, Gottardi E, et al. Consistent amounts of acute leukemia-associated P190 bcr/abl transcript are expressed by chronic myelogenous leukemia patients at diagnosis. Blood. 1996;87:1075-1080.
15. Saglio G, Guerrasio A, Rosso C, et al. New type of bcr/abl junction in Philadelphia chromosome positive chronic myelogenous leukemia. Blood. 1990;76:1819-1825.
16. Dhingra K, Kurzrock R, Kantarjian H, et al. Minimal residual disease in interferon-treated chronic myelogenous leukemia: results and pitfalls of analysis based on polymerase chain reaction. Leukemia. 1992;6,:754-760.
17. Niederhauser C, Hofelein C, Wegmuller B, Luthy J, Candrian U. Reliability of PCR decontamination systems. Am J Pathol. 1994;144:486-491.
18. Young KK, Archer JJ, Yokosuka O, Omata M, Resnick RM. Detection of hepatitis C virus RNA by a combined reverse transcription PCR assay: comparison with nested amplification and antibody testing. J Clin Microbiol. 1995;33:654-657.
19. Kox LF, Rhienthong D, Miranda AM, et al. More reliable PCR for detection of Mycobacterium tuberculosis in clinical samples. J Clin Microbiol. 1994;32:672-678.
20. Melo JV, Yan HX, Diamond J, et al. Reverse transcription polymerase chain reaction amplification of very small numbers of transcripts: the risk in misinterpreting negative results. Leukemia. 1996;10:1217-1221.
21. F Pane, F Frigeri, M Sindona, et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with specific molecular marker (BCR/ABL with C3/A2 junction). Blood. 1996;88:2410-2414.
22. Bartram CR, Kleihauer E, de Klein a, et al. C-abl and bcr are rearranged in a Ph-negative CML patient. EMBO J. 1985;4:683-686.
23. Preudhomme C, Feneaux P, Lai JI, et al. Philadelphia positive adult acute lymphoblastic leukemia in 2 of 39 patients with combined cytogenetic and molecular analysis. Leukemia. 1993;7:1054-1057.
24. Inazawa J, Nishigaki H, Takahira H, et al. Rejoining between 9q+ and Philadelphia chromosomes results in normal looking chromosome 9 and 22 in Ph negative chronic myelocytic leukemia. Hum Genet. 1989;83:115-118.
25. Morris C, Kennedy M, Heisterkamp N, et al. A complex chromosome rearrangement forms the BCR-ABL fusion gene in leukemic cells with a normal karyotype. Genes Chromosomes Cancer. 1991;3:263-271.
26. Lestingi TM, Hooberman AL. Philadelphia chromosome positive acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 1993,7:161-175.
27. Arnoldous EJP, Wiegant J, Nordermeer IA, et al. Detection of the Philadelphia chromosome in interphase nuclei. Cytogenet Cell Genet. 1990;54:108-111.
28. Tkachuk DC, Westbrook CA, Andreeff M, et al. Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization. Science. 1990;250:559-250.
29. Bentz M, Cabot G, Moos M, et al. Detection of chimeric bcr-abl genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood. 1994;83,7:1922-1928.
30. Zhang J, Meltzer P, Jenkins R, Guan X-Y, Trent J. Application of chromosome microdissection probes for elucidation of bcr-abl fusion and variant Philadelphia chromosome translocations in chronic myelogenous leukemia. Blood. 1993;81:3365-3371.
31. Dewald GW, Schad CR, Christensen ER, et al. The application of in situ fluorescent hybridization to detect Mbcr/abl fusion in variants Ph chromosomes in CML and ALL. Cancer Genet Cytogenet. 1993;71:7-14.
32. Cox Froncillo MC, Cantonetti M, Masi M, et al. Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia patients on interferon-a (IFN-a) therapy. Cancer Genet Cytogenet. 1995;84:15-18.
33. Cox Froncillo MC, Maffei L, Cantonetti M, et al. FISH analysis for CML monitoring? Ann Hematol. 1996;73:113-119.
34. Nolte M, Werner M, Ewig M, et al. Fluorescence in situ hybridization (FISH) is a reliable diagnostic tool for detection of the 9;22 translocation. Leuk Lymphoma. 1996;22:287-294.
35. Stasi R, Del Poeta G, Venditti A, et al. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0) Blood. 1994 83:1619-1625.
36. Venditti A, del Poeta G, Stasi R, et al. Minimally differentiated acute myeloid leukemia (AML-MO): cytochemical, immunophenotypic and cytogenetical analysis of 19 cases. Br J Haematol. 1994;88:784-793.
37. Bain BJ. Leukaemia Diagnosis: A Guide to the FAB Classification. Philadelphia, Pa: Lippincott; London, England: Gower Medical Publishing; 1993.
38. Prchal JT, Prchal JF. Evolving understanding of cellular defect in polycythemia vera for its clinical diagnosis and molecular pathophisiology. Blood. 1994;83:1-4.
39. Rooney DE, Czepulolkowski BH. Human Cytogenetics: A Practical Approach. Oxford, England: IRL Press; 1992.
40. Mitelman F. ISCN: Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Basel, Switzerland: Karger; 1991.
41. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-164.
42. Kwok S, Higuchi R. Avoiding false positive with PCR. Nature. 1989;339:237.
43. Morris CM, Heisterkamp N, Kennedy MA, et al. Ph-negative chronic myeloid leukemia: molecular analysis of ABL insertion into M-BCR on chromosome 22. Blood. 1991;76:1812-1818.
44. Hagemeijer A, Buijs A, Smith E, et al. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative BCR-positive patients with chronic myeloid leukemia. Genes Chromosomes Cancer. 1993;8:237-245.
45. Biernaux C, Loos M, Sels A, Huez G, Stryckmansm P. Detection of major bcr-abl gene expression at very low level in blood cells of some healthy individuals. Blood. 1995;86:3118-3122.
46. Frenoy N, Chabli A, Sol O, et al. Application of a new protocol for nested PCR to the detection of minimal residual bcr/abl transcripts. Leukemia. 1994;8:1411.